Related Experiment Video
Updated: Jun 20, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Re: [177Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p):
Elio Mazzone1, Sachin Perera2, Abhijeet L Neti3
1Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Gianfranco Soldera Prostate Cancer Laboratory, Division of Oncology/Unit of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
No abstract available in PubMed .
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020